DE60026569D1 - Zusammensetzungen auf der basis von gfr-alpha-4 und deren anwendungen - Google Patents

Zusammensetzungen auf der basis von gfr-alpha-4 und deren anwendungen

Info

Publication number
DE60026569D1
DE60026569D1 DE60026569T DE60026569T DE60026569D1 DE 60026569 D1 DE60026569 D1 DE 60026569D1 DE 60026569 T DE60026569 T DE 60026569T DE 60026569 T DE60026569 T DE 60026569T DE 60026569 D1 DE60026569 D1 DE 60026569D1
Authority
DE
Germany
Prior art keywords
seq
polypeptides
present
gfralpha4
mammalian
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60026569T
Other languages
English (en)
Other versions
DE60026569T2 (de
Inventor
Matti Airaksinen
Mart Saarma
Dimitri Friedrich-Mi Poteriaev
Maria Lindahl
Toenis Timmusk
Jari Rossi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Licentia Oy
Original Assignee
Licentia Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Licentia Oy filed Critical Licentia Oy
Application granted granted Critical
Publication of DE60026569D1 publication Critical patent/DE60026569D1/de
Publication of DE60026569T2 publication Critical patent/DE60026569T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
DE60026569T 2000-02-21 2000-11-14 Zusammensetzungen auf der basis von gfr-alpha-4 und deren anwendungen Expired - Fee Related DE60026569T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20000394A FI20000394A0 (fi) 2000-02-21 2000-02-21 GFRa4:n sukuisia tai siitä johdettuja aineita sekä niiden käyttö
FI20000394 2000-02-21
PCT/FI2000/000994 WO2001062795A1 (en) 2000-02-21 2000-11-14 COMPOUNDS RELATED TO OR DERIVED FROM GFRα4 AND THEIR USE

Publications (2)

Publication Number Publication Date
DE60026569D1 true DE60026569D1 (de) 2006-05-04
DE60026569T2 DE60026569T2 (de) 2007-02-08

Family

ID=8557643

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60026569T Expired - Fee Related DE60026569T2 (de) 2000-02-21 2000-11-14 Zusammensetzungen auf der basis von gfr-alpha-4 und deren anwendungen

Country Status (9)

Country Link
US (1) US7488588B1 (de)
EP (1) EP1257581B1 (de)
JP (1) JP2003523762A (de)
AT (1) ATE319743T1 (de)
AU (1) AU782897B2 (de)
CA (1) CA2397705A1 (de)
DE (1) DE60026569T2 (de)
FI (1) FI20000394A0 (de)
WO (1) WO2001062795A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016025880A1 (en) 2014-08-14 2016-02-18 Novartis Ag Treatment of cancer using gfr alpha-4 chimeric antigen receptor
WO2016025884A1 (en) * 2014-08-14 2016-02-18 The Trustees Of The University Of Pennsylvania Glycosyl-phosphatidylinositol (gpi)-linked gdnf family alpha-receptor 4 (gfralpha4)-specific antibody and uses thereof
US11802159B2 (en) 2019-09-30 2023-10-31 The Trustees Of The University Of Pennsylvania Humanized anti-GDNF family alpha-receptor 4 (GRF-alpha-4) antibodies and chimeric antigen receptors (CARs)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455277B1 (en) * 1996-04-22 2002-09-24 Amgen Inc. Polynucleotides encoding human glial cell line-derived neurotrophic factor receptor polypeptides
WO1999050298A1 (en) * 1998-03-31 1999-10-07 Millennium Pharmaceuticals, Inc. GFRα-X, A NOVEL GLIAL-DERIVED NEUROTROPHIC FACTOR RECEPTOR AND USES THEREFOR
FI981217A (fi) * 1998-05-29 1999-11-30 Matti S Airaksinen GFRalfa2 negatiiviset hiiret toimivat kokeellisina malleina eräille ihmisen taudeille
GB9915200D0 (en) * 1999-06-29 1999-09-01 Janssen Pharmaceutica Nv Neurotrophic factor receptor

Also Published As

Publication number Publication date
DE60026569T2 (de) 2007-02-08
ATE319743T1 (de) 2006-03-15
EP1257581A1 (de) 2002-11-20
CA2397705A1 (en) 2001-08-30
AU1527101A (en) 2001-09-03
US7488588B1 (en) 2009-02-10
AU782897B2 (en) 2005-09-08
JP2003523762A (ja) 2003-08-12
EP1257581B1 (de) 2006-03-08
WO2001062795A1 (en) 2001-08-30
FI20000394A0 (fi) 2000-02-21

Similar Documents

Publication Publication Date Title
BR9710665A (pt) Compostos que promovem o desenvolvimento do tecido
AR008588A1 (es) Molecula de acido nucleico aislada que hibridiza con un gen de saliva de pulga, proteina aislada codificada por dicha molecula, composicion terapeuticapara tratar la dermatitis alergica, kit de ensayo para determinar dicha dermatitis, molecula, virus y celula recombinantes, y anticuerpo aislado
WO2001055327A3 (en) Nucleic acids, proteins, and antibodies
WO2001054472A3 (en) Nucleic acids, proteins, and antibodies
WO2001055306A8 (en) Nucleic acids, proteins, and antibodies
ATE290079T1 (de) Metabotropische gaba(b) rezeptoren, rezeptoren- spezifische liganden und deren anwendungen
ATE378408T1 (de) Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren
FI930626A (fi) Proteinstruktur hos vaexttoxingelonin
DE60026569D1 (de) Zusammensetzungen auf der basis von gfr-alpha-4 und deren anwendungen
WO2004042000A3 (en) 157 human secreted proteins
WO2001055168A8 (en) Nucleic acids, proteins and antibodies
ATE336508T1 (de) Kaliumkanalprotein kcnq5, ein ziel für erkrankungen des zentralen nervensystems und herz-gefäss-systems
SE9804274D0 (sv) Novel receptor
WO2001055449A8 (en) Nucleic acids, proteins, and antibodies
WO2001055162A8 (en) Nucleic acids, proteins, and antibodies
WO2001055305A8 (en) Nucleic acids, proteins, and antibodies

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee